Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia

NCT02302469 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom Macroglobulinemia

Interventions

DRUG: Revlimid

Sponsor

University Hospital, Lille

Collaborators

[object Object]